Clinical trials
Obese clinical trials
Below are recruiting obese clinical trials, each written for real people, not researchers. We’re tracking 1,433 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06254261RecruitingPhase 2
RAY1225 for weight loss in obesity
This study tests an investigational medication called RAY1225 in people with obesity. It's given as an injection and may help with weight loss by targeting hormones that control appetite.
Beijingcun, HebeiAges 18–70 - NCT07280936RecruitingPhase 1
Study of SHR-2906 in healthy people and those with obesity
This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.
Hangzhou, ZhejiangAges 18–55 - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Birmingham, AlabamaAges 18 years+ - NCT07279194RecruitingPhase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
ShanghaiAges 18 years+ - NCT07283406Enrolling by invitation
High-intensity interval training for young adults with obesity
This study tests whether high-intensity interval training (short bursts of intense exercise) can improve heart health and fitness in young adults with obesity. You would participate in a supervised exercise program to see if it helps lower your risk of future health problems.
Guadalajara, JaliscoAges 18–35 - NCT07284108Enrolling by invitation
Healthy eating for my infant: a program for new moms
This study helps new moms who are feeling stressed or down learn healthy ways to feed their baby. It offers support and education to prevent infant obesity, and may include home grocery delivery.
Cincinnati, OhioAges 2 months–1.8 years - NCT07283978Enrolling by invitation
Testing digital tools for weight management
This study looks at using digital tools like apps to help manage weight. It's for people in a specialized weight management program in South East London.
London, Greater LondonAges 18 years+ - NCT06885255Recruiting
Fasting and Exercise for Metabolic Syndrome
This study tests whether combining intermittent fasting with exercise can lower inflammation and improve your metabolism and gut health in people with metabolic syndrome.
Erlangen, BavariaAges 18–80 - NCT06890169Recruiting
One-stop telehealth program for weight and diabetes
This trial tests a telehealth program that helps people lose weight and manage type 2 diabetes and fatty liver disease at the same time. It's a one-stop remote clinic that combines medical advice, nutrition, and lifestyle support.
SingaporeAges 21–70 - NCT05966727Recruiting
Cholestyramine to lower stored pollutants in obese women
This study tests whether cholestyramine can lower blood levels of certain stored environmental pollutants (“POPs”) in women preparing for weight-loss surgery. If it works, it may help reduce pollutant levels that can build up in the body over time.
Nice, Alpes-MritimesAges 18–45 - NCT05759637Recruiting
Tests treatments for diabetes, weight, and high cortisol levels
This trial studies people who have type 2 diabetes and excess body weight, looking at how high cortisol (a stress hormone) may be involved. If you qualify, you may get a study treatment designed to improve diabetes and weight-related health by targeting cortisol-related pathways.
MilanAges 18–75 - NCT06847373Recruiting
Vitamin D for teens with obesity
This study is testing whether vitamin D supplements can help teens with obesity. It is open to participants aged 10 to 18 who live in Mexico City and have obesity based on their BMI.
MéxicoAges 10–18 - NCT07268417Enrolling by invitation
Group lifestyle program for obesity in primary care
This study tests if group medical visits with lifestyle coaching can help people with obesity lose weight and improve their health. It takes place at Cleveland Clinic primary care offices.
Cleveland, OhioAges 20–75 - NCT07261475RecruitingEarly Phase 1
Saffron petal extract for weight and blood sugar
This study tests a water extract from saffron flower petals to see if it helps with weight loss or blood sugar control in people with obesity or prediabetes. It's an early-phase trial, so it's looking at safety and how the body handles the extract.
IzolaAges 40–65 - NCT07255209RecruitingPhase 3
A study of IBI362 for Chinese teens with obesity or overweight
This trial tests a new medicine, IBI362, to help Chinese adolescents lose weight. It may be an option if you are 12 to 17 years old and have obesity or overweight with a related health condition.
Hangzhou, ZhejiangAges 12–18 - NCT07253155Enrolling by invitation
Probiotics for preventing gut symptoms in overweight adults
This study tests whether taking probiotics can help prevent stomach and gut discomfort in people who are overweight or have obesity. You may be eligible if you are at a certain weight and age, eat a balanced diet, and do not have chronic gut issues.
ColeraineAges 18 years+ - NCT07254065Recruiting
Preventing obesity early with telehealth support
This study tests a telehealth program to help prevent obesity in pregnant women. It offers support and education through video calls to promote healthy habits.
New Hyde Park, New YorkAges 18 years+ - NCT07247084RecruitingPhase 4
Tirzepatide for weight loss in adults with obesity
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
AltrinchamAges 18 years+ - NCT07245771RecruitingPhase 1/Phase 2
Weight loss study testing a new drug alone or with tirzepatide
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
Melbourne, VictoriaAges 18–65 - NCT07243171RecruitingPhase 1/Phase 2
Oral Ecnoglutide for overweight or obesity
This trial tests an oral medication called Ecnoglutide to help people with overweight or obesity lose weight. It is for Chinese adults who are not diabetic and have a stable weight.
Beijing, Beijing MunicipalityAges 18–65 - NCT07242534RecruitingPhase 4
Semaglutide for better embryos in IVF for women with overweight or obesity
This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.
Sabadell, BarcelonaAges 18–38 - NCT02902198Recruiting
Study of taste changes before and after bariatric surgery
This study looks at how your sense of taste works before and after bariatric weight-loss surgery. It may help doctors understand why eating patterns change after surgery.
BaselAges 18–55 - NCT07231484Recruiting
Grape study for immune and gut health in obesity
This trial tests if eating grapes every day for 4 weeks can improve your immune system and gut health. It is designed for adults with obesity who are willing to keep their diet and activity stable during the study.
Columbia, MissouriAges 18–60 - NCT07230808Recruiting
Obesity prevention program for parents in home visiting
This trial offers a digital program to help parents prevent childhood obesity. It's designed for families already in a home visiting program and aims to support healthy growth in babies born healthy and on time.
Gainesville, FloridaAges 16–65
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obese?
- Yes. Clin2 currently lists 1,433 recruiting obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.